Portfolio (Quarterly)
Guide ↗
Soleus Capital Management, L.P.
· CIK 0001802630| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | XBI PUT | SPDR SERIES TRUST | — | 2,900,000.0 | $353.6M | 13.04% | NEW | — | $121.93 | +8.0% |
| 2 | KRYS | KRYSTAL BIOTECH INC | Healthcare | 941,059.0 | $232.0M | 8.56% | NEW | — | $246.54 | +21.5% |
| 3 | CELC | CELCUITY INC | Healthcare | 1,808,258.0 | $180.4M | 6.65% | NEW | — | $99.74 | +38.6% |
| 4 | NVCR | NOVOCURE LTD | Healthcare | 8,530,665.0 | $110.3M | 4.07% | NEW | — | $12.93 | +38.9% |
| 5 | — | PRAXIS PRECISION MEDICINES I | — | 362,966.0 | $107.0M | 3.95% | NEW | — | $294.74 | — |
| 6 | TGTX | TG THERAPEUTICS INC | Healthcare | 3,139,312.0 | $93.6M | 3.45% | NEW | — | $29.81 | +30.4% |
| 7 | DXCM | DEXCOM INC | Healthcare | 1,297,094.0 | $86.1M | 3.18% | NEW | — | $66.37 | +8.6% |
| 8 | BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | 1,320,000.0 | $78.4M | 2.89% | NEW | — | $59.43 | -9.0% |
| 9 | — | GLOBUS MED INC | — | 887,000.0 | $77.4M | 2.86% | NEW | — | $87.31 | — |
| 10 | BBNX | BETA BIONICS INC | Healthcare | 2,534,565.0 | $77.2M | 2.85% | NEW | — | $30.47 | -61.2% |
| 11 | FOLD | AMICUS THERAPEUTICS INC | Healthcare | 5,207,284.0 | $74.2M | 2.73% | NEW | — | $14.24 | +1.8% |
| 12 | TWST | TWIST BIOSCIENCE CORP | Healthcare | 1,861,802.0 | $59.1M | 2.18% | NEW | — | $31.72 | +91.0% |
| 13 | ORGO | ORGANOGENESIS HLDGS INC | Healthcare | 9,985,951.0 | $51.7M | 1.91% | NEW | — | $5.18 | -48.6% |
| 14 | SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | 2,247,110.0 | $47.2M | 1.74% | NEW | — | $21.01 | -5.1% |
| 15 | MIRM | MIRUM PHARMACEUTICALS INC | Healthcare | 573,614.0 | $45.3M | 1.67% | NEW | — | $78.99 | +24.9% |
| 16 | PODD | INSULET CORP | Healthcare | 150,000.0 | $42.6M | 1.57% | NEW | — | $284.24 | -45.5% |
| 17 | NPCE | NEUROPACE INC | Healthcare | 2,703,208.0 | $41.7M | 1.54% | NEW | — | $15.44 | +9.6% |
| 18 | AXGN | AXOGEN INC | Healthcare | 1,206,855.0 | $39.5M | 1.46% | NEW | — | $32.73 | +25.0% |
| 19 | ANIP | ANI PHARMACEUTICALS INC | Healthcare | 486,243.0 | $38.4M | 1.42% | NEW | — | $78.94 | +4.8% |
| 20 | ALKS | ALKERMES PLC | Healthcare | 1,322,364.0 | $37.0M | 1.36% | NEW | — | $27.98 | +31.5% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%